Molecular Cytogenetics Market Size and Share Is Projected to Grow at a 24.2% CAGR By 2027, Finds Coherent Market Insights

The black-and-white cytogenetics approaches are giving way to colour cytogenetics. With the development of FISH and aCGH, traditional black and white approaches were associated with difficulties in resolution and accuracy. Complex chromosomal rearrangements are detected using molecular cytogenetic techniques like as FISH and aCGH.

Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2491

Statistics:

The global molecular cytogenetics market is estimated to account for US$ 1,970.8 Mn in terms of value by the end of 2019.

Global Molecular Cytogenetics Market: Drivers

The worldwide molecular cytogenetics market is predicted to rise due to the approval and launch of new products. For example, in January 2019, Applied Spectral Imaging launched an updated products portfolio that included a new imaging methodology that is based on an all-new algorithm coupled with advanced hardware components to increase the scanning speed for fluorescence in situ hybridization (FISH) imaging.

Global Molecular Cytogenetics Market: Opportunities

For companies in the worldwide molecular cytogenetics market, the advent of Next Generation Sequencing (NGS) is likely to provide lucrative growth prospects. In October 2019, Illumina, Inc. teamed with QIAGEN N.V. to expand the availability and usage of NGS-based in-vitro diagnostic kits for patient management, including companion diagnostics.

“Limited Time Offer”

Buy This Research Study Report With Flat US $2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/2491

Global Molecular Cytogenetics Market: Restraints
The worldwide molecular cytogenetics market is projected to be hampered by the low adoption of molecular cytogenetics in emerging nations.

Key Takeaways:

The global molecular cytogenetics market was valued at US$ 1,970.8 million in 2019 and is expected to grow at a CAGR of 24.2 percent to US$ 11,129.1 million by 2027. The worldwide molecular cytogenetics market is predicted to rise due to the approval and launch of new products.

aCGH segment held dominant position in the global molecular cytogenetics market in 2019, accounting for 64.0% share in terms of value, increasing prevalence of cancer is expected to propel the segment growth during the forecast period.

Market Trends

The global molecular cytogenetics market is predicted to develop due to the high frequency of genetic abnormalities. The number of patients with cystic fibrosis climbed from 21,421 in 2003 to 30,775 in 2018, according to the Summary of the Cystic Fibrosis Foundation Patient Registry, 2003–2018.

To increase their market share, major companies in the global molecular cytogenetics market are focusing on forming partnerships. Precipio, Inc., a specialist diagnostics firm, for example, announced in April 2018 that it is inactive licensing conversations with multiple possible partners about IV-Cell, Precipio's patented cytogenetics media.

Global Molecular Cytogenetics Market: Competitive Landscape

Major players operating in the global molecular cytogenetics market include, Abbott Laboratories, Affymetrix, Inc., Agilent Technologies, Inc., Applied Spectral Imaging, Inc., BI Biological Industries, Bio-Rad Laboratories, CytoTest Inc., Cytognomix, Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Bionano Genomics, Inc., Precipio, Inc., and Leica Biosystems.

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/molecular-cytogenetics-market-3402

Global Molecular Cytogenetics Market: Key Developments

The worldwide molecular cytogenetics market's major companies are focusing on launching new products in order to grow their product portfolio. For example, in March 2019, Bionano Genomics, Inc. launched multiple new products and advancements for its Saphyr workflow that massively improve throughput, significantly speed up sample prep and allow for the detection of low-allele frequency structural variants at the 2019 Advances in Genome Biology and Technology (AGBT) meeting.

To understand Research Methodology, please click https://www.coherentmarketinsights.com/market-insight/molecular-cytogenetics-market-2491

Segmentation

Scope of the report
• Global Molecular Cytogenetics Market, By Technology:
o FISH
o aCGH

• Global Molecular Cytogenetics Market, By Application:
o Genetic Disorders
o Cancer
o Personalized Medicine
o Others

• Global Molecular Cytogenetics Market, By Region:
o North America
 By Technology:
 FISH
 aCGH
 By Application
 Genetic Disorders
 Cancer
 Personalized Medicine
 Others
 By Country
 U.S.
 Canada
o Latin America
 By Technology:
 FISH
 aCGH
 By Application
 Genetic Disorders
 Cancer
 Personalized Medicine
 Others
 By Country
 Brazil
 Mexico
 Argentina
 Rest of Latin America
o Europe
 By Technology:
 FISH
 aCGH
 By Application
 Genetic Disorders
 Cancer
 Personalized Medicine
 Others
 By Country
 U.K.
 Germany
 France
 Spain
 Italy
 Russia
 Rest of Europe
o Asia Pacific
 By Technology:
 FISH
 aCGH
 By Application
 Genetic Disorders
 Cancer
 Personalized Medicine
 Others
 By Country
 China
 Japan
 India
 Australia
 South Korea
 ASEAN
 Rest of Asia Pacific
o the Middle East
 By Technology:
 FISH
 aCGH
 By Application
 Genetic Disorders
 Cancer
 Personalized Medicine
 Others
 By Country
 GCC Countries
 Israel
 Rest of the Middle East
o Africa
 By Technology:
 FISH
 aCGH
 By Application
 Genetic Disorders
 Cancer
 Personalized Medicine
 Others
 By Country
 North Africa
 Central Africa
 South Africa

Have a Look at Related Research Insights:

Global Healthcare Simulators Market – Insights - https://www.pharmiweb.com/press-release/2021-06-15/healthcare-simulators-simulation-based-medical-teaching-and-learning-market-growth-to-register-a-cagr-of-147-to-reach-us-4-5968-million-by-2027

Global Wearable Patch Market – Insights - https://www.pharmiweb.com/press-release/2021-06-15/wearable-patch-all-in-one-health-monitor-market-size-to-expand-at-highest-revenue-us-1-6605-million-with-growth-rate-at-229-cagr-by-2027

Global Respiratory Drug Delivery Formulation Market Analysis - https://www.pharmiweb.com/press-release/2021-06-15/respiratory-drug-delivery-formulation-market-drug-delivery-to-the-lungs-challenges-and-opportunities-analysis-2021-2026-1

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

This release was published on openPR.